Transcription of GUIDELINES ON VALIDATION APPENDIX 4 …
{{id}} {{{paragraph}}}
Working document June 2016 Draft document for comment 1 GUIDELINES ON VALIDATION APPENDIX 4 2 ANALYTICAL METHOD VALIDATION 3 (June 2016) 4 DRAFT FOR COMMENTS 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 World Health Organization 2016 25 All rights reserved. 26 This draft is intended for a restricted audience only, the individuals and organizations having received this draft. The draft 27 may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any 28 form or by any means outside these individuals and organizations (including the organizations' concerned staff and member 29 organizations) without the permission of the World Health Organization.
Working document QAS/16.671 page 3 90 Background information 91 92 The need for revision of the published Supplementary guidelines on good manufacturing practices: validation 93 (1) was identified by the Prequalification of Medicines Programme and a 94 draft document was circulated for comment in early 2013. The focus of the revision …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Subject: Certificate of Analysis for USP Reference, Subject: Certificate of Analysis for USP Reference Standards, To Quality in Analytical Chemistry, ANALYTICAL CHEMISTRY, ANALYTICAL CHEMISTRY Standards, For analytical laboratory use — Specification, For analytical laboratory use — Specification and, Guidance for Industry, Guidance for Industry Analytical, SILICA, CRYSTALLINE by IR KBr pellet, Analytical